INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
HJ

Hoitt Jason

Chief Patient OfficerCIK 0001762572

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 5
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$25K
748 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Stoke Therapeutics, Inc.Chief Patient Officer · Mar 19, 2026
32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL
$4,419
139 sh
Mar 18, 2026
Mar 19, 2026
traded Mar 18, 2026
+1d
SEC FORM 4

Evidence

32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$986
30 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

40
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$34K
1,033 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC FORM 4

Evidence

39
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$55K
1,762 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence